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Abstract
Background:
Spine pain is a common presenting complaint of patients who visit physicians and although spine cancer accounts for a
very small percentage of cases of back pain, metastasis is a relatively common cause of spine pain in the elderly.  The
presentation of patients with spine cancers is highly variable, and in many cases the clinical findings of benign and
cancerous causes of spine pain can be similar, often confounding the clinical picture.  This can create difficulties in
interpreting the clinical data available to the physician, particularly with a disease with such a devastating prognosis.
Objective:
This manuscript discusses the more common causes of malignant lesions of the spine, including an overview of the
incidence/prevalence data and clinical features of both primary and secondary malignancies.  It also provides the reader
with a clinical overview of patients with spine cancer.
Discussion:
It is important to appreciate the myriad epidemiologic and clinical features of primary and secondary spine cancers.
Patients with malignant skeletal lesions may be asymptomatic in the area of cancerous bone disease and, as a consequence,
these lesions can be overlooked.  This may result in dismal consequences for the patient, given the generally poor prognosis
associated with spine cancers.  Knowledge of the features discussed in this paper will assist the clinician in appropriately
raising his/her index of suspicion for spine cancer in suitable clinical circumstances.
The purpose of this paper is to present an overview of the
epidemiology and presentation of spine cancer, including
findings that should suggest to the physician that a patient
may have a spine malignancy and also to describe the
incidence/prevalence, sex preference, location and clinical
presentation of the more common malignancies of the spine.
Overview of Osseous Malignancies
Bone is comprised of both an inorganic matrix and the protein
matrix surrounding it.  Bone cells include osteoprogenitor
cells, osteoblasts, osteoclasts and osteocytes, any of which
can form the base for an osseous malignancy.
Cancer is an abnormal, purposeless mass of tissue, the growth
of which exceeds, and is uncoordinated with, that of normal
host tissue.  It preys on the host and it is virtually autonomous.
Cancers can range histologically from well-differentiated to
poorly differentiated (anaplastic).
The process by which cell overgrowth occurs and eventually
leads to malignancy is divided into 4 basic steps and includes
hyperplasia, metaplasia, dysplasia and neoplasia.
1. Hyperplasia is a simple increase in the number of cells
which remain under normal physiologic control.
Hyperplasia is reversible.  An example of hyperplasia
is an increase in done density at the margin of a joint
in patients with osteoarthritis.
2. Metaplasia is an adaptive substitution of one adult
tissue type with another adult tissue type.
3. Dysplasia is abnormal cell growth, with disordered
cellular orientation, atypical cellular morphology,
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Introduction
Spine pain is a very common presenting complaint of patients
visiting medical practitioners, chiropractors and osteopaths,
affecting approximately 80% of the population at some point
in their lives1.  Mechanical dysfunction, including sprains
and strains, are common reasons for back pain.  Back pain is
considered one of the ten most costly physical health
conditions2 and it is quite common for a patient to have more
than one episode of spine pain throughout his/her life3,4.
Fortunately, most cases of spine pain are caused by non-
malignant lesions such as mechanical disorders5, however
the clinical presentation of benign and malignant causes of
spine pain can be relatively similar.
Back pain presents most typically as either a sequelae of an
acute traumatic event or with insidious onset.  It is those cases
with insidious onset that present more of a diagnostic
challenge, where it becomes critically important to formulate
a working diagnosis.  This is because the institution of
appropriate therapy may have a profound effect on the
patient’s life, including longevity.10
increased cell proliferation, and reduced cellular
maturation. It is typically considered pre-neoplastic.
4. Neoplasia is a condition where the normal growth
regulating mechanisms of cells are altered.
The natural ordered progression from normal tissue to cancer
is hyperplasia/metaplasia to dysplasia to cancer in situ to
invasive cancer to metastasis.  Metastasis is the spread of a
malignancy beyond the host organ.
The incidence (number of new cases per unit of time) of spine
cancer varies according to the type of physician practice.  In
a primary care practice, Deyo and Diehl6 found an incidence
of spine malignancy of 0.66% of 1,975 patients.  Slipman,
et.al.7 demonstrated an incidence of 0.12% in the private
practice of a physiatrist and 0.69% in an academic health
center.
The clinical presentation of patients with spine malignancies
can vary from asymptomatic to a syndrome involving wasting
and cachexia.  Slipman, et.al.7 present an in-depth discussion
of the symptomatology of patients with spine tumors.  The
most salient point in their review is the fact that 94% of
patients with spine malignancy reported the spontaneous onset
of symptoms without any recent history of trauma.  Most
patients that visit physicians with a complaint of back pain
will report antecedent trauma or injury.  The insidious onset
of new back pain, particularly in an older patient7 should
raise suspicion of a malignancy.  The pain seen in patients
with spinal neoplasms may be the result of spinal cord
compression, nerve root compression, soft tissue invasion,
cortical expansion of the vertebra, fracture or instability.  The
presence of radiculopathy, therefore does not rule out the
existence of a malignant spinal lesion.  Myelopathy/cauda
equina syndrome occurs in approximately 5-20% of patients8.
The pain may also be associated with a co-morbidity not at
all associated with the malignancy, such as a sprain/strain.  A
painful scoliosis may also be the result of a spine tumor.
Other relatively consistent characteristics of patients with
spine malignancy (Table 1) include pain, which is typically
described as aching7, age over 506,7, night pain7, a previous
history of cancer6,7, and prior medical care without relief6,7.
Pain is not a ubiquitous finding.  Palmer et al, found that
approximately 20% of patients with confirmed metastasis
were asymptomatic.  In addition they found that only a small
percentage (15-23%) of metastatic sites were painful9.  Further
confirmation of the frequency of pain in cancer patients is
supplied by Wagner10.  An additional confounding factor is
that approximately 30% of patients are diagnosed with
metastases before their primary tumors are identified11.
A generalized feeling of weakness is a consistent finding
amongst patients with spine malignancies, affecting up to 70%
of patients by the time of diagnosis12.  This weakness is more
often related to weight loss, fatigue and anemia than to spinal
cord or nerve root compression.
Interestingly, unexplained weight loss was seen in only 15-
24% of patients6,7.  Low grade fever can be a sign of
malignancy, but only 2% of patients were febrile in Slipman’s
study7, while none had a fever in Deyo’s study6.  Women
were affected slightly more often than men in one study6 while
there was an equal sex distribution in the other7.  The average
duration of symptoms before the patient sought medical
attention was over one month in both studies6,7.  In the Spilman
study, the average visual analog scale pain rating was 6.8 on
a scale of 1-107.
The most common cancer of the spine is metastasis6,7 with
breast cancer in women and prostate cancer in men as the
most common primary malignancies resulting in metastatic
lesions6,7.  Spine cancer can be osseous or soft tissue in
location, affecting spinal, paraspinal and intra-canalicular
tissues.  Primary malignant tumors affect 23%6 and 14%7 of
patients respectively.  Lymphoma6 and ependymoma7 were
the most common primary tumor types.  The most common
spinal region affected by malignancy was the lumbar spine7.
It is critical to note that whether a spine malignancy is primary
or metastatic, the clinical presentation of patients is similar
in both instances6.  This makes the differentiation of the origin
of the tumor difficult from a clinical standpoint and biopsy
will most often be the confirmatory test in making this
distinction.  One helpful sign is the presence of multiple
lesions on diagnostic imaging studies, which is highly
suggestive of metastasis.
Primary Osseous Spinal Malignancies
Primary malignancies of the spine are uncommon when
compared to metastasis.  Multiple myleoma and chordoma
Table 1.  Clinical Characteristics of Patients with Spinal
Malignancy
• Pain
• Night pain
• Age > 50
• Previous history of cancer
• Previous treatment without relief
• Genaeralized weakness
• Fatigue
• Weight loss
• Low-grade fever
Spine Cancer:  A Summary and Review
WYATT11 Volume 12 • Number 1 • July 2004 | ACO
are the two most common primary tumors affecting the spine.
Others include osteosarcoma, chondrosarcoma, Ewing’s
sarcoma and giant cell tumor.  Table 2 outlines the typical
radiographic appearances of primary spinal neoplasms.
Multiple Myeloma
Multiple myeloma, also known as, plasma cell myleoma, is a
malignant lesion of bone marrow involving cancerous
transformation of plasma cells, and it represents the most
common primary skeletal malignancy.  The most common
forms are IgG and IgA myelomas.  It is the second most
common hematologic malignancy, behind non-Hodgkin’s
lymphoma, and affects approximately 6 people per 100,000
population.  It represents approximately 1% of all
malignancies.  People of African descent, particularly men,
are most commonly affected.  In fact, myeloma is one of the
top ten causes of cancer deaths in African-Americans, with
this sub-population affected twice as often as Causasians13.
Multiple myeloma can affect any bone in the body and soft
tissues organs as well.  Common symptoms include bone pain,
often worse at night, fatigue, renal problems (proteinuria,
polyuria, uremia, renal failure), and recurrent infections
secondary to immunocompromise.  Bone pain is noted most
often in the thoraco-lumbar spine and ribs, while the skull
may also be affected.  Rarely, hepatosplenomegaly and/or
lymphadenopathy may be seen.  Complications from
myeloma including hyperproteinemia may also result in a
blood hyperviscosity syndrome with dyspnea, chest pain, and
even central nervous system sequelae, including
microinfarcts.  Cryoglobulinema, another complication of
myeloma, may result in pain, numbness and tingling in the
fingers and toes, especially in cold weather.  Amyloidosis is
another rare complication in myeloma patients.  In rare cases,
myeloma may be found incidentally on blood tests performed
for some other reason.
Laboratory testing most often reveals a classic “M” spike on
serum protein electrophoresis secondary to elevations in M
(monoclonal) protein levels.  Proteinuria is also common,
secondary to the deposition of light-chain Bence-Jones
proteins.  These proteins are produced by the plasma cells
seen with myeloma.
Plain film radiography typically demonstrates diffuse
osteopenia of the spine and/or “punched-out” lesions in the
spine, ribs, pelvis and skull.  Conventional technetium-99
MDP bone scans are notably negative in most patients with
myeloma.  Newer radiopharmaceuticals, such as technetium-
99m 2-methoxyisobutylisonitrile (99mTc-MIBI) purport to
find many more cases14 and positron emission tomography
with [(18)F] fluorodeoxyglucose (FDG PET)15 appear to have
high diagnostic yields.  Magnetic resonance imaging (MRI)
not only finds marrow lesions in the spine but the paraspinal
masses so common in most patients16. Bone marrow aspiration
confirms the diagnosis.
Prognosis for patients with myeloma is dependent upon
staging, with cases of symptomatic myeloma being almost
universally terminal.  The most commonly used system is
the Durie-Salmon Staging System17.  The mean length of
survival is 33 months18.
Chordoma
Chordoma is a rare tumor.  However, excluding
lymphoproliferative malignancies, chordoma is the most
common primary malignant tumor of the spine in adults.
These tumors arise from remnants of the notochord, which
represents the earliest fetal axial skeleton.  Chordoma occurs
most commonly in patients aged 30-60 years, with the peak
incidence in the 5th decade.  They generally have an equal
sex distribution, but spinal chordomas occur more commonly
in men.  Chordomas occur most commonly in the
sacrococcygeal region, particularly the fourth and fifth sacral
segments.  The other common location is the spheno-occipital
region.  The cervical spine, particularly C2, and the lumbar
spine are the most common sites of spinal chordoma, when it
develops above the sacrum.
Malignancy Radiographic findings
Multiple myeloma Diffuse osteopenia, “punched-out”
lesions in flat bones, negative Tc-99
MDP bone scan, positive 99m Tc-
MIBI scan, positive FDG PET scan.
Chordoma Large midline destructive lesion, large
soft tissue mass, disc space/SI joint
involvement, involves sacrum, upper
cervical spine.
Osteosarcoma Sclerotic lesion(s) in vertebral body,
“ivory vertebra”, soft tissue mass.
Chondrosarcoma Mixed matrix lesion with cortical
destruction, soft tissue mass, may cross
disc space.
Ewing’s sarcoma Sclerotic lesion most often,
occasionally lytic/mixed, soft tissue
mass, involves veetebral body.
Giant cell tumor Lytic lesion of vertebral body,
expansile, may be a soft tissue mass.
Table 2.  Diagnostic Imaging Findings in Primary Skeletal
Malignancies
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Clinical presentation is insidious, with a gradual onset of
neurologic symptoms, including pain, numbness, motor
weakness, and incontinence or constipation in sacral lesions.
Chordomas are slowly growing lesions but, unfortunately,
are often very large, bulky masses when initially discovered.
No specific blood tests are available for the diagnosis of
chordoma.  Non-specific laboratory findings, including a mild
white blood cell count elevation and anemia may be seen.
Radiographically, most chordomas cause a destructive
midline lesion with a large associated soft-tissue mass.
Interestingly, there may be intervertebral disk involvement
with narrowing of the disc space, which is unusual for most
spinal tumors.  This appearance may simulate infectious
discitis.  Similarly, sacrococcygeal chordomas may extend
across the sacroiliac joint.  Magnetic resonance
imaging(MRI), because of its multiplanar capabilities and
exquisite contrast resolution, is the best modality to uncover
the nature and extent of the lesion.
The prognosis of chordoma depends on whether the tumor
can be completely resected.  Generally, patients with
sacrococcygeal lesions have an improved survival rates
compared with patients who have chordomas at other sites,
with an average 5-year survival rate of approximately 50%.
Symptoms from metastasis to a distant organ may be the initial
presentation.
Osteosarcoma
Osteosarcoma is a primary bone tumor comprised of
malignant osteoid cells that most often affects the
appendicular skeleton, particularly around the knee.  It is the
most common primary malignant tumor of childhood, with
the incidence peaking between the ages of 15-19.
Osteosarcoma of the spine is an unusual tumour with less
than 5% of all osteosarcomas involving the spine.  Patients
with spine lesions typically present at an older age than those
with appendicular lesions, with most patients in their fourth
decade of life at presentation.  Men are affected more often
than women.
Osteosarcomas have a notable predilection for the
lumbosacral spinal segments.  The vertebral body is most
often involved, but extension into the posterior elements is
also common.  Occasionally, primary involvement of the
posterior elements occurs.
The clinical presentation often includes pain and an enlarging
palpable mass.  Patients will very often have neurologic
symptoms from an associated soft tissue mass.  Of particular
note, is that osteosarcoma of the spine can be secondary to
radiation exposure, and it can also be a secondary malignancy
associated with Paget’s disease.
Laboratory investigation may reveal elevated serum alkaline
phosphatase (AkP) and lactate dehydrogenase (LDH) levels.
Patients with elevated AkP are more likely to have pulmonary
metastasis and those with elevated LDH levels have a poorer
prognosis as well.
Plain film radiography findings are dependent upon the cell
type of the lesion, but most lesions are blastic with an
associated soft tissue mass.  An “ivory vertebra” may also be
seen.  Computerized tomography (CT) and MRI are useful
for evaluating the extent of the lesion and the soft-tissue
involvement that is often present.  Lesions may remain low
signal intensity on all MR pulse sequences secondary to large
amounts of matrix ossification.
The size of these lesions and the close proximity of neurologic
structures makes these patients poor candidates for surgical
excision of the tumor mass and a therefore a poor prognosis
is the rule, with death usually occurring within 1 year.
Chondrosarcoma
Chondrosarcoma is a primary skeletal malignancy containing
an exclusively chondroid tissue matrix.  It is the second most
common adult non-lymphoproliferative primary malignant
tumor of the spine.  Generally speaking, however, the spine
is an uncommon primary site for this tumor.  Men are affected
two to four times more frequently than women and the most
patients are in their fourth or fifth decade at the time of
diagnosis.  These tumors are seen at all levels of the spine,
although the thoracic spine is the most common location.
Patients typically present with pain and a palpable paraspinal
mass along with neurologic symptoms.  This constellation of
symptoms is relatively common with  primary spinal skeletal
malignancies.
Chondrosarcoma typically causes cortical destruction and
extension into the surrounding soft tissues.  These findings
are best depicted by CT or MRI.  Mineralization is usually
apparent in the soft-tissue component of the lesion.
Involvement of adjacent vertebral levels by extension through
the disk is also seen in approximately 35% of lesions.  This
appearance mimics infectious discitis.
Chondrosarcoma of the spine is usually a relatively low-grade
lesion.  Cure is possible if the lesion is amenable to complete
resection.  Five-year survival rates vary between 30-90%
based upon the grade of the lesion, with lower grade lesions
resulting in longer survival rates.
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Ewing’s Sarcoma
Ewing’s sarcoma is the most common primary malignant
tumor of non-lymphoproliferative origin in the spine in
children.  It is thought to be a malignant tumor arising from
neural crest cells, although the exact cellular origin is currently
unknown.  Lesions of the spine are unusual; however,
metastatic foci of Ewing’s sarcoma in the spine may occur.
Patients usually present between the ages of 10 and 30 years.
The most common location of Ewing’s sarcoma in the spine
is the sacral region.  Other spinal regions are also affected,
although involvement of the cervical spine is rare.  Lesions
are typically located in the vertebral body, although extension
into the posterior elements is not uncommon.
Clinical symptoms include pain and neurologic changes,
including loss of bowel and bladder control, although it is
not uncommon for these lesions to be asymptomatic or only
minimally symptomatic until later in the course of the disease.
Radiographs of Ewing’s sarcoma may reveal a permeative
lytic lesion, osseous expansion, or sclerosis, with sclerosis
being the most prominent pattern in many cases involving
the spine.  The findings on MRI are generally non-specific,
but the study does demonstrate surrounding soft-tissue
involvement to the best advantage.
Radiation therapy and chemotherapy are the current mainstays
of treatment for spinal lesions, with results approaching 100%
for local control and 86% for long-term survival for patients
with non-sacral tumors.  Sacral tumors have a worse
prognosis, which is most likely related to the larger tumor
size because of delayed clinical presentation compared with
other spinal lesions.
Giant Cell Tumor
Giant Cell Tumor (GCT) is a lesion comprised primarily of
osteoclasts.  The spine is an uncommon location for GCT.
Most occur in the sacrum followed by the thoracic, cervical,
and lumbar regions, respectively.  These tumors are more
common in women and occur in the third to fifth decades of
life, with most of them being benign.  Giant cell tumors of
the spine are generally found in patients aged 20 and under.
An important note is that malignant GCTs are often related
to previous irradiation in the region of eventual development
of the tumor.
The symptoms of spinal GCT include pain, at times with
neurologic symptoms, including radiculopathy.  Painful
scoliosis can also be seen.
Spinal GCTs are usually radiolucent and expansile on plain
film radiography.  When present in the sacrum, these lesions
are large with destruction of the sacral foramina.
Computerized tomography and MRI are helpful in defining
the nature and extent of these lesions.
Five-year survival for malignant GCTs is approximately 50%
while survival rates for benign lesions is higher.
Approximately 1/3 of lesions recur after surgical resection.
Bony Spinal Metastasis
Metastasis is the spread of cancer cells from the host organ
to another.  It can occur by direct extension, lymphatic spread
or hematogenous spread.  The skeleton is the third most
common locale for metastasis, following the lung and liver.
Most skeletal metastases are the result of a primary carcinoma
while sarcomatous metastasis to the skeleton is comparatively
unusual.
Approximately 50% of patients who die from cancer have
bony metastases at the time of death, with the spine being the
most common metastatic skeletal location.  Spinal metastases
are far more common than primary malignancies with three-
quarters or more of lesions representing metastatic lesions7.
Skeletal metastases are most common from prostate cancer
in men and breast cancer in women.  Deyo and Diehl6
demonstrated that malignancy was the cause of back pain in
13 of 1975 patients with back pain.
Other cancers that commonly metastasize to the spine include
lung cancer, renal cancer and gastric cancer. Sixty percent of
skeletal metastasis occur in the axial skeleton19.  The most
common location for bony spinal metastasis is the thoracic
spine (70%), followed by the lumbar spine (20%) and finally
the cervical spine (10%).
It is not uncommon for signs and symptoms from spinal
metastasis to be the initial presenting complaint of patients
with primary malignancies elsewhere.  This is particularly
true for lung cancer.  Typical signs and symptoms include
pain, which is often worse at night and can be associated
with walking or standing, weight loss, and fatigue7.
These patients are generally older than those patients with
primary malignant spinal tumors.  In addition, approximately
5-10% of patients with advanced metastases have
hypercalcemia and may experience symptoms associated with
it.  Pathologic fractures are relatively common.
The radiographic appearance of osseous metastasis in the
spine is variable.  Three basic forms are generally seen: lytic,
blastic and mixed.  Lytic lesions demonstrate a decrease in
radiographic bone density, blastic lesions exhibit an increase
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and mixed lesions reveal a combination of the two.  The
radiographic presentation is most dependent upon the primary
lesion.  Table 3 summarizes the common radiographic
findings of metastasis affecting the spine.
The differential diagnosis of osseous metastasis to the spine
includes infection, hemangioma, primary bone tumors, both
benign and malignant, osteoporosis, including osteoporotic
fracture, and metabolic bone disease.
The median survival rate for patients with spinal metastases
is approximately 10 months.  The long-term survival rates
are best for renal cell carcinoma, followed by breast, prostate
and lung metastases20.
Lung Cancer Metastasis
After breast and prostate cancer, lung cancer is the third most
common site of origin of metastasis to bone.  Most patients
are over age 50 and a history of smoking is almost always
present.
Pain is the most common presenting symptom.  It is not
uncommon for these patients to have no other manifestation
of cancer other than a painful spinal lesion.  Pathological
compression fracture also occurs.  When a patient has a
metastasis and no organ of origin can be found, the most
likely site of primary malignancy is the lung or kidney.
Hypertrophic pulmonary osteoarthropathy may also be
identified in some patients.
It is not uncommon to find signs and symptoms of
hypercalcemia, including tetany-like syndromes, in these
patients.  They may also be anemic and have elevated white
blood cell counts.
From a radiographic perspective, lung metastasis to the spine
is typically lytic, although cases of blastic and even mixed
lesions are not unheard of.  The classic presentation is a
smoker over 40 with multiple bone lesions with back pain
with or without sciatica.
Lung cancer with metastasis to bone has a very unfavorable
prognosis.  Only 2% of patients with metastasis survive to
five years21.  The average survival after the diagnosis of
metastasis is approximately 6 months.
Breast Metastasis
Breast cancer is the most common site of origin of metastasis
to the skeleton.  In fact, over 50% of women with breast
cancer have skeletal metastases22.  The most common cause
of pathological fracture is metastatic breast cancer.
Spine pain is a common presenting symptom of breast cancer
metastsis.  Patients with metastases to the spine may also
demonstrate the signs and symptoms classically associated
with breast cancer or may have had a previous mastectomy
or breast-conserving treatment.  These signs include
lymphadenopathy, weight loss and skin changes associated
with local recurrence.  The classic clinical appearance of
breast metastasis is a woman over age 40 with a history of
breast cancer and multiple bone lesions.
With lytic metastasis, clinical signs and symptoms of
hypercalcemia may also be present.  Patients may also have
anemia and an elevated white blood cell count, in addition to
laboratory findings associated with metastasis to other organs
(e.g., liver).
The radiographic appearance of breast cancer can be lytic,
blastic or mixed.  The lesions are often blastic, but may also
be purely lytic.  Metastasis tends to occur in the thoracolumbar
spine most commonly.
The average survival after the diagnosis of a breast cancer
metastasis to bone has dramatically improved to about 24-
36 months secondary to the use of biphosphonate
chemotherapeutic agents.  The five-year survival rate is
approximately 22% for patients with breast metastasis21.
Prostate Metastasis
Prostate metastasis is the most common skeletal metastasis
in men.  Men of African descent have the highest incidence
of prostate carcinoma.  In addition to the symptoms noted
above for spinal metastasis, patients with prostate cancer may
also demonstrate polyuria, especially at night, difficulty
starting urination, incontinence, the inability to urinate, weak
or interrupted urine stream, dysuria, erectile dysfunction,
painful ejaculation or blood in the urine or semen.
Skeletal metastases are quite common in prostate cancer.
Most patients with prostatic adenocarcinoma eventually
Table 3.  Common Radiographic Findings in Metastasis to the
Spine
• Compression fracture(typically “pathologic”
collapse)
• Missing pedicle
• Uniformly sclerotic “ivory” vertebra
• Multiple lytic/blastic/mixed lesions
• Isolated lytic/blastic/mixed lesion
• Cortical destruction
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develop skeletal metastases and, in many patients, these are
present at the time of initial diagnosis.
Laboratory investigation in the patient with prostate
metastasis may reveal elevated levels of prostate specific
antigen, acid phosphatase and alkaline phosphatase.  These
patients may also have anemia and neutrophilia.
The lumbar spine and pelvis are the most common regions
for osseous prostate metastasis and the radiographic
presentation is typically a patchy blastic appearance.  In some
cases, the entire vertebral body is affected creating a uniformly
sclerotic appearance.  Pathologic fracture is unusual
secondary to the blastic nature of the lesions.  Radionuclide
bone scanning demonstrates increased uptake of radiotracer
at the tumor sites.
While the overall survival rate for all stages of prostate cancer
approaches 80%, skeletal metastases are associated with poor
prognosis with only 33% of patients surviving beyond five
years21.
Renal Metastasis
Renal cell cancers rank relatively high as a cause of metastatic
deposits in the spine.  This tumor has several unique features
that are worthy of discussion.  For example, the metastatic
deposits may occur many years after the primary tumor has
been treated.  Therefore, patients who seem to be cured after
treatment for a renal cell carcinoma should be monitored for
up to ten years for possible bone metastasis.  Secondly,
metastasis may occur as a solitary focus of disease.  En bloc
surgical resection of a solitary metastasis may offer a cure in
some cases.
Although the number of cases of this cancer is proportionately
small, the tumor has a high affinity for creating bone
metastasis.  Most patients are over age 40.
Pain is the most common presenting symptom.  Pathological
fracture can occur, but not typically without a history of
increasingly severe pain.  Systemic symptoms from
hypercalcemia may also occur.  An occasional patient may
have hypertension.  A painful spinal lesion may be the only
manifestation of cancer because the primary tumor can grow
fairly large without creating local symptoms.  When present,
local symptoms of the primary tumor include flank pain or a
mass in the abdomen.  Hematuria is also a common sign, but
it is often microscopic and not identified by the patient.  As
mentioned previously, when a patient has metastasis and no
primary tumor has yet been found, the most likely site of the
primary tumor is the lung or kidney.  Kidney cancers are
notorious for being very large, due to their propensity to
extend into the soft tissues surrounding the bone.  A patient
over age 40 with hematuria and a large bone lesion should be
assumed to have renal metastasis until proven otherwise.
Laboratory findings may include hematuria, either gross or
microscopic, elevated blood urea nitrogen levels, elevated
creatinine levels, anemia and neutrophilia.
Most cases of renal cell carcinoma metastasis in the spine
produce a lytic pattern of bone destruction.  A soft tissue
mass may also be seen.  CT and/or MRI can help delineate
soft tissue involvement.
Kidney cancer with metastasis to bone can be a very
aggressive tumor and patients with multiple bone lesions at
presentation have an unfavorable prognosis.  The average 5-
year survival rate in one study was 55%23, while only 10% of
those with metastasis survive for five years or more22.
Malignant Melanoma
Metastasis to the spine from malignant melanoma is unusual,
whereas metastases to other soft tissue locations is the rule.
Melanoma can occur at any age, but is unusual in small
children.  Most patients are in the fifth decade of life.  This
tumor occurs more commonly in men and the highest
incidence is in patients with a great deal of sun exposure.
The most common symptom of spinal metastasis from
melanoma is pain.  There is normally a history of a cutaneous,
oral or ocular lesion as well.
No specific laboratory test for the diagnosis of malignant
melanoma is currently available.  Interestingly, patients with
elevated levels of LDH have a less favorable prognosis and
this test is now used as part of the staging system for this
disease.
Patients with spinal metastasis from melanoma have a very
poor prognosis.  Median survival after the diagnosis of
metastasis is approximately four months24.
Squamous Cell Carcinoma
Squamous cell carcinoma (SCC), is the second most common
cancer in humans representing between 15-20% of human
cancers.  Australians have the highest rate of SCC in the world;
with an incidence of disease more than double that in the
United States.  It is strongly associated with excessive sun
exposure and is therefore most commonly seen on the head
and neck, and particularly on the face.  Men are affected
more often than women and the disease is most commonly
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seen in patients aged 55-75.  Tobacco smoking has also been
associated with SCC, but typically only after 20 or more years
of smoking.  It generally arises at the location of a pre-existing
area of actinic keratosis.
Metastasis occurs in approximately 3-10% of cases depending
upon the aggressiveness of the lesion.  Most cases of
metastases occur in the lungs and are usually associated with
a specific sub-type of SCC called baso-squamous
carcinoma25.  Metastasis to the skeleton is present in
approximately 1/3 of cases26.
Metastasis to the spine generally produce localized pain and
discomfort, with no particularly specific signs or symptoms
associated with SCC metastasized to the spine, except for
the presence of a skin lesion somewhere on a sun-exposed
area of the body.
Laboratory testing is non-contributory.
Metastasis to the spine from a SCC is rare, but most commonly
occurs in the thoracic spine where the lesions can be lytic,
blastic or mixed.
Cure rates approach 95% for localized skin lesions without
metastasis.  Once the tumor has metastasized, however, the
prognosis is quite bleak with over 95% of patients succumbing
to the disease within one year.
Clinical Pearls
There are a number of important and at times, diagnostic
features of some of the lesions discussed in this paper.  The
following clinical findings are important in the assessment
of patients with spinal cancer.
• The insidious spontaneous onset of spine pain,
particularly in a relatively older patient, without
antecedent trauma, is highly suspicious for malignancy.
• Patients with spine cancers may not have pain,
particularly at all lesion locations.
• Back and/or leg pain from metastasis may precede the
discovery of a primary malignancy.
• By far, the most common cancer of the spine is
metastasis; prostate metastases in men and breast
metastases in women.
• Multiple skeletal lesions are most suggestive of
metastasis.
• Multiple myleoma is the most common primary
skeletal malignancy of the spine.
• Chordomas and chondrosarcomas can cross joint/disc
spaces.
• Always inlcude chordoma in the differential diagnosis
of destructive sacral lesions.
• Fifty per cent of patients with malignancy have bone
metastasis.
• Patients with lytic metastasis may have signs and
symptoms of hypercalcemia.
• Multiple bone lesions in a woman with a history of
breast cancer is highly suggestive of metastasis.
• Multiple bone lesions is a smoker over 40 is suggestive
of lung cancer metastasis.
• Metastatic renal cell carcinoma may occur many years
after treatment of the initial tumor.
• Metastasis from renal cancer may be a solitary locally
excisable lesion.
Summary
The average prevalence of cancer, dependent upon the
geographic region under study, is approximately 2-3%27.
Spine cancer is a common and most often a devastating
condition, although it accounts for <1% of the causes for
back pain6.  Metastasis is the most common lesion, followed
by multiple myleoma.  Other primary tumors of the spine are
uncommon, if not rare.  Patients with spinal malignancies
can present with myriad clinical syndromes and most of them
have an insidious onset of pain.  Generally, the prognosis for
long-term survival is poor.
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